Cell Therapies
MabDesign’s market analyses give you a monthly overview of market dynamics and projects in development for a given indication or technology, to help you better understand the constantly evolving market of biologics and biomanufacturing. This month, an overview of the market and pipeline of cell therapies.
Therapeutic antibodies
MabDesign’s market analyses give you a monthly overview of market dynamics and projects in development for a given indication or technology, to help you better understand the constantly evolving market of biologics and biomanufacturing. This month, an overview of the market and pipeline of therapeutic antibodies.
Human Immunodeficiency Virus
The MabDesign market analysis gives you an overview of market dynamics and projects currently in development for the prevention and treatment of Human Immunodeficiency Virus (HIV).
Therapies based on genome editing
The MabDesign market analysis gives you an overview of market dynamics and projects currently in development for the therapies based on genome editing.
Antibody-oligonucleotides conjugates
Each month, MabDesign’s market analyses give you an overview of market dynamics and projects in development for a given indication or technology, to help you better understand the constantly evolving market for biomedicines and biomanufacturing. This month, an overview of antibody-oligonucleotide conjugate (AOC) projects currently in development.
Gene therapies
This month’s MabDesign market analysis gives you an overview of the gene therapy market and projects currently in development.
Bioproduction of viral vectors: challenges, innovations and market prospects
Viral vectors are essential therapeutic tools for gene therapy and certain vaccines. The growing number of cell and gene therapy products on the market means that the production of viral vectors is an increasingly strategic sector.
Respiratory syncitial virus
This month’s MabDesign market analysis gives you an overview of market dynamics and projects in development targeting respiratory syncitial virus (RSV).
Infectious diseases
This month, MabDesign’s market analysis gives you an overview of projects in development in the field of infectious diseases.
breast cancer
The MabDesign market analysis for this month of pink October gives you an overview of market dynamics and projects in development targeting the treatment of breast cancer.
Multiple Sclerosis
This month’s MabDesign market analysis gives you an overview of market dynamics and development projects targeting the treatment of multiple sclerosis.
The immuno-oncology market
Long considered as cellular debris with no biological function, exosomes, and more generally extracellular vesicles (EVs), are now recognized as vectors of biological material with a role in intercellular communication. The building of knowledge on the subject has not only highlighted their role in certain pathologies, but also revealed their potential as biomarkers and therapeutic tools.
Glioblastoma
This month’s MabDesign market analysis gives you an overview of market dynamics and pipeline projects targeting the glioblastoma.
Cell and gene therapies
The first edition of our Innovations for Cell and Gene Therapies (ICGT) congress, organized in collaboration with the Société Française de Thérapie Cellulaire et génique (SFTCG), will take place on May 22, 2024, in Paris. In the meantime, this month we share an overview of the cell and gene therapy market.